$60.56
0.070.11%
At close: -
Virtus LifeSci Biotech Products ETF (ARCA: BBP)
Ticker | Name | Share % | |
---|---|---|---|
ADMA | Adma Biologics Inc Com | 4.54% | |
INSM | Insmed Inc | 3.66% | |
TARS | Tarsus Pharmaceuticals Inc | 3.31% | |
MRNA | Moderna therapeutics | 3.19% | |
DCPH | Deciphera Pharmaceuticals Inc | 3.10% | |
AGIO | Agios Pharmaceuticals Inc | 3.01% | |
SRPT | Sarepta Therapeutics Inc | 2.64% | |
PTCT | Ptc Therapeutics Inc | 2.53% | |
LXRX | Lexicon Pharmaceutcl | 2.51% | |
BPMC | Blueprintmedicines Corp. | 2.42% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
BBP follows a Mid Cap Growth investment style.
The top holdings of BBP include: ADMA (4.54%), INSM (3.66%), TARS (3.31%), MRNA (3.19%), DCPH (3.1%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for BBP is currently not available.